We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




DNA Bricks Have Potential Applications in Several Nanotech and Biotech Fields

By LabMedica International staff writers
Posted on 25 Dec 2013
Researchers have been exploiting the unique physical properties of DNA in order to develop applications not related to its role in storing genetic information.

Investigators at Harvard Medical School (Boston, MA, USA) have relied on highly purified oligonucleotides obtained from Integrated DNA Technologies (Coralville, IA, USA) to create three-dimensional DNA constructs or "bricks.” These bricks have potential applications in several different fields such as catalysts in the development of drug compounds or as elements to create electrical circuit boards on the nanometer scale.

A DNA brick is a relatively simple, single-stranded, 32-base DNA oligonucleotide construct. More...
Each brick has four consecutive eight-base domains, and they assemble at right angles to complementary interlocking oligonucleotides guided by these eight-base domains. A computer program developed in the laboratory of Dr. Pen Yin, assistant professor of systems biology at Harvard Medical School, then "paints" the oligonucleotides onto a virtual molecular canvas that is represented as 10 x 10 x 10 cubic volumetric pixel elements or "voxels.” A three-dimensional shape is created by withholding individual voxels from the brick, and the software then determines which oligonucleotides are required to form the resulting three-dimensional canvas structure.

DNA bricks can be easily modified with other functional molecules, such as fluorophores, and can serve as a scaffold for growing other molecular matrices, such as those formed from SiO2, which have many material applications.

Related Links:

Harvard Medical School
Integrated DNA Technologies



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
PlGF Test
Quidel Triage PlGF Test
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.